Premium
P2‐353: Reducing the availability of soluble Aβ halts progression of cerebral amyloid angiopathy in transgenic mice
Author(s) -
Prada Claudia M.,
Garcia-Alloza Monica,
Fine Sara,
Betensky Rebecca A.,
Ebiana Victoria,
Greenber Steven M.,
Bacskai Brian J.,
Frosch Matthew P.
Publication year - 2008
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2008.05.1431
Subject(s) - gelsolin , cerebral amyloid angiopathy , genetically modified mouse , medicine , in vivo , pathology , amyloid (mycology) , transgene , chemistry , biology , disease , actin , biochemistry , dementia , gene , microbiology and biotechnology